|Company name||Neogen Corporation|
|Live stock price||[stckqut]NEOG[/stckqut]|
|P/E compared to competitors||Fair|
|Confident Investor Rating||Fair|
|Target stock price (TWCA growth scenario)||$72.52|
|Target stock price (averages with growth)||$92.51|
|Target stock price (averages with no growth)||$59.72|
|Target stock price (manual assumptions)||$64.5|
The following company description is from Google Finance: http://www.google.com/finance?q=neog
Neogen Corporation (Neogen), together with its subsidiaries, develops, manufactures, and markets a diverse line of products dedicated to food and animal safety. It is engaged in developing and marketing test kits that provide food safety solutions. The Company’s food safety segment consists primarily of diagnostic test kits and complementary products (dehydrated culture media) sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, drug residues, pesticide residues and general sanitation concerns. These products are marketed in North America, the United Kingdom and other parts of Europe, Mexico and Brazil and by distributors through the rest of the world. In October 2012, it acquired the stock of Macleod Pharmaceuticals. In January 2013, the Company acquired the assets of Scidera Genomics, LLC.
Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.
If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.